Home / Market News / $BLLN

$BLLN news and market catalysts

The 9 most recent market catalysts affecting $BLLN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

9 catalysts 2 high impact 4 bullish 4 bearish Biotechnology
Nov 18, 2026 Corporate Catalyst Bearish Impact 75
BillionToOne Responds to Short Seller Report
BillionToOne (BLLN) has issued a strong rebuttal to a short seller report from Fuzzy Panda Research, which alleged inaccuracies and distortions. This is a significant event because…
Nov 18, 2026 Corporate Catalyst Bearish Impact 75
BillionToOne Shares Fall Following Short Report
BillionToOne's stock experienced a significant drop on November 18, 2026, after Fuzzy Panda released a short report detailing concerns about the company. This event is a direct neg…
Nov 5, 2026 Corporate Catalyst Bullish Impact 55
BillionToOne, Inc. 12-Month Price Target Adjusted by Analysts
This 8-K filing indicates that the average 12-month price target for BillionToOne, Inc. (BLLN) has been slightly increased by analysts from $129 to $129.71. This adjustment, while …
Oct 1, 2026 Corporate Catalyst Bullish Impact 55
Guggenheim Maintains Buy on BillionToOne, Raises Price Target to $128
Guggenheim analyst Subbu Nambi maintained a 'Buy' rating on BillionToOne (BLLN) and raised the price target from $125 to $128. This action signals a continued positive sentiment fr…
Sep 23, 2026 Corporate Catalyst Bullish Impact 65
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS is proposing significant changes to Medicare's clinical laboratory fee schedule, aiming to reduce payments by aligning them with private sector rates. This is a long-term initi…
Sep 2, 2026 Corporate Catalyst Neutral Impact 65
Canaccord Genuity Initiates Coverage On BillionToOne with Buy Rating, Announces Price Target of $120
Canaccord Genuity initiating coverage on BillionToOne with a 'Buy' rating and a $120 price target is a positive development for the company. Analyst coverage, especially with a str…
Aug 6, 2026 Corporate Catalyst Bearish Impact 95
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
BillionToOne (BLLN) announced impressive Q2 2026 results, showcasing strong revenue growth, a return to profitability, and increased test volumes. The company also maintained its f…
Aug 5, 2026 Corporate Catalyst Bearish Impact 65
BillionToOne Affirms FY2026 Sales Guidance of $450.000M-$465.000M vs $456.440M Est
BillionToOne (BLLN) filed an 8-K to affirm its fiscal year 2026 sales guidance, keeping the range at $450 million to $465 million. This is a routine disclosure when a company reite…
Aug 5, 2026 Corporate Catalyst Bullish Impact 92
BillionToOne Q3 EPS $0.15 Misses $0.19 Estimate, Sales $109.400M Beat $109.365M Estimate
BillionToOne's Q3 earnings per share of $0.15 missed the analyst consensus of $0.19 by 21.05%, a notable miss that could concern investors regarding profitability. However, the com…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.